The baseline workbook is the single source for FY23 planning, quota-setting, and revenue forecasting assumptions. It reflects expected commercial reality and is updated through governance review.
Externally: describe as temporary accommodations tied to market conditions and continuity of supply. Internally: use “planning assumption” language; avoid “reset/new normal” phrasing.
Exceptions are limited and must be logged. As of July 2022, Alpine Medical is modeled at post-June 2022 pricing in the base case due to documented tender sensitivity; all other top accounts follow standard escalation or repricing frameworks.